Constellation Brands, Inc. (STZ) is a leading producer and marketer of premium wine, beer, and spirits in the United States, Canada, Mexico, and other international markets. The company has a diversified portfolio of alcoholic beverage brands, including Corona, Modelo, Robert Mondavi, and Svedka Vodka.
From a financial perspective, STZ has a solid track record of revenue growth and profitability. In the fiscal year 2021, the company reported net sales of $9.2 billion, representing a 3% increase from the prior year. The company's net income also increased by 15% to $2.2 billion. The company has consistently generated positive free cash flow, which allows it to invest in growth initiatives, pay dividends, and repurchase shares.
In terms of profitability ratios, STZ has a strong gross margin of 47%, indicating that the company generates significant profits on the products it sells. The company's operating margin is also healthy at 30%, indicating that it is efficient in managing its operating expenses.
STZ has a strong balance sheet, with a current ratio of 1.4 as of September 2021, indicating that it has sufficient short-term assets to cover its liabilities. The company has a moderate debt-to-equity ratio of 0.77, which is lower than the industry average, indicating that it has a conservative debt profile.
From a valuation perspective, STZ's stock price appeared to be trading at a premium valuation as of September 2021, with a price-to-earnings (P/E) ratio of 25.5, which is higher than the industry average. However, investors may be willing to pay a premium for STZ's strong financial performance, growth prospects, and market leadership.
In conclusion, based on the fundamental analysis, STZ appears to be a solid company with a strong financial position, consistent revenue growth, and healthy profitability ratios. However, it is important to note that market conditions and other factors can impact a stock's performance, and investors should conduct their own research and analysis before making any investment decisions.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.